Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease (2017)
- Authors:
- USP affiliated authors: BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; ULRICH, ALEXANDER HENNING - IQ
- Unidades: ICB; IQ
- DOI: 10.3727/096368917X695227
- Subjects: DOENÇA DE PARKINSON; ESTRESSE OXIDATIVO; RECEPTORES DOPAMINÉRGICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Cell Transplantation
- ISSN: 0963-6897
- Volume/Número/Paginação/Ano: v. 26, n. 4, p. 669-677, 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
FERRAZOLI, Enéas Galdini et al. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease. Cell Transplantation, v. 26, n. 4, p. 669-677, 2017Tradução . . Disponível em: https://doi.org/10.3727/096368917X695227. Acesso em: 31 mar. 2026. -
APA
Ferrazoli, E. G., Souza, H. D. N. de, Nascimento, I. C. do, Giacomelli, Á. O., Schwindt, T. T., Britto, L. R. G. de, & Ulrich, H. (2017). Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease. Cell Transplantation, 26( 4), 669-677. doi:10.3727/096368917X695227 -
NLM
Ferrazoli EG, Souza HDN de, Nascimento IC do, Giacomelli ÁO, Schwindt TT, Britto LRG de, Ulrich H. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease [Internet]. Cell Transplantation. 2017 ; 26( 4): 669-677.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3727/096368917X695227 -
Vancouver
Ferrazoli EG, Souza HDN de, Nascimento IC do, Giacomelli ÁO, Schwindt TT, Britto LRG de, Ulrich H. Brilliant blue G, but not fenofibrate, treatment reverts hemiparkinsonian behavior and restores dopamine levels in an animal model of Parkinson's disease [Internet]. Cell Transplantation. 2017 ; 26( 4): 669-677.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3727/096368917X695227 - Proliferation and differentiation of embryonic cells to neurons depende on purinergic receptor-induced calcium transients
- Carvacrol promotes neuroprotection in the mouse hemiparkinsonian model
- Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells
- Expression and activity of nicotinic and muscarinic acetylcholine receptors during neuronal differentiation In vitro
- Neuronal cell fate determination in P19 embryonic carcinoma cells is dependent on spontaneous calcium oscillations
- P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation
- New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders
- Participation of spontaneous 'CA POT. 2+'-transients and 'CA POT. 2+'-fluxes generated by purinergic and nicotinic acetylcholine receptors in neuronal differentiation of P19 embryonic carcinoma cells
- Pharmachological properties and proliferation-inducing effects of purinergic receptors in P19 embryonal cells as In vitro model for neuronal differentiation
- Mechanism of acetylcholine-induced calcium signaling, proliferation and differentiation effects during In vitro neuronal differentiation of embryonal cells
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
